Theravance Biopharma, Inc. (FRA:0TB)
Germany
· Delayed Price · Currency is EUR 15.90
-0.20 (-1.24%)
At close: Dec 5, 2025
Theravance Biopharma Revenue
Theravance Biopharma had revenue of $19.99M USD in the quarter ending September 30, 2025, with 18.51% growth. This brings the company's revenue in the last twelve months to $80.33M, up 27.12% year-over-year. In the year 2024, Theravance Biopharma had annual revenue of $64.38M with 12.12% growth.
Revenue (ttm)
$80.33M
Revenue Growth
+27.12%
P/S Ratio
11.80
Revenue / Employee
$828.11K
Employees
97
Market Cap
808.00M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64.38M | 6.96M | 12.12% |
| Dec 31, 2023 | 57.42M | 6.08M | 11.84% |
| Dec 31, 2022 | 51.35M | -3.97M | -7.17% |
| Dec 31, 2021 | 55.31M | -16.55M | -23.03% |
| Dec 31, 2020 | 71.86M | -1.56M | -2.12% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |